Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · IEX Real-Time Price · USD
1.020
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.030
+0.010 (0.98%)
Pre-market: Jul 22, 2024, 6:39 AM EDT

Oragenics Revenue

Oragenics had revenue of $20.63K in the twelve months ending March 31, 2024. In the year 2023, Oragenics had annual revenue of $37.65K.

Revenue (ttm)
$20.63K
Revenue Growth
-84.54%
P/S Ratio
275.94
Revenue / Employee
$4,126
Employees
5
Market Cap
5.69M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202337.65K-93.87K-71.37%
Dec 31, 2022131.52K44.53K51.20%
Dec 31, 202186.99K--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 2014939.93K-92.31K-8.94%
Dec 31, 20131.03M-299.53K-22.49%
Dec 31, 20121.33M-112.68K-7.80%
Dec 31, 20111.44M135.54K10.35%
Dec 31, 20101.31M667.63K104.11%
Dec 31, 2009641.29K407.75K174.59%
Dec 31, 2008233.54K100.45K75.48%
Dec 31, 2007133.09K66.91K101.11%
Dec 31, 200666.18K--
Dec 31, 20050--
Dec 31, 2004196.21K--
Dec 31, 20030--
Dec 31, 20020--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sonoma Pharmaceuticals 12.74M
Biomerica 5.41M
TFF Pharmaceuticals 885.72K
Titan Pharmaceuticals 87.00K
Ainos -28.44K
Revenue Rankings